KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer - Concepedia

Concepedia

Publication | Open Access

KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer

DOI Full Paper Access

13

Citations

44

References

2022

Year

Keitaro Shimozaki, Eiji Shinozaki, Noriko Yamamoto, Yu Imamura, Hiroki Osumi, Izuma Nakayama, Takeru Wakatsuki, Akira Ooki, Daisuke Takahari, Mariko Ogura,

Journal of Cancer Research and Clinical Oncology

MedicineKras MutationGastroenterologyPathologyInsufficient Trastuzumab EfficacyCancer GenomicsGastric CancerCancer GeneticsOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1

Page 1